Comparison of two formulations of intravenous lipid emulsions in pediatric intestinal failure

The effect of different types of lipid emulsion may guide therapy of patients with intestinal failure (IF) to limit morbidity such as intestinal failure-associated liver disease (IFALD). A retrospective chart review of pediatric patients with IF who received soybean oil lipid emulsion (SL) or mixed oil lipid emulsion (ML) was performed. Data over 1 year were collected. Forty-five patients received SL and 34 received ML. There were no differences in the incidence (82 versus 74